Concurrent Session 14:
Xenotransplantation I

Chairs: Wayne Hancock and Donald Cramer

Return to the Agenda:

NOTE: You can search this pageby using your browser's "Find" function
(under the "Edit" menu in Netscape Navigator/Communicator and Microsoft Internet Explorer)

11:00 #442 Immunoadsorption technique in orthotopic xenotransplantation of pig hearts in baboons.

P Brenner, H Reichenspurner, M Schmoeckel, A Rucker, C Wimmer, V Eder, M Hinz, T Felbinger, C Hammer and B Reichart, Munich, Germany

11:10 #443 Regulated endothelial cell expression of novel molecules with anticoagulant properties: a strategy for the prevention and therapy of vascular rejection.

A Dorling, D Chen, K Riesbeck and RI Lechler, London, UK

11:20 #444 Prolonged survival or orthotopic cardiac xenografts in an hDAF transgenic pig-to-baboon model.

CM Vial, FNK Bhatti, DJ Ostlie, E Cozzi, M Goddard, G Pino-Chavez, M Schmoeckel, A Zaidi, J Wallwork, DJG White and JJ Dunning, Cambridge and Papworth Everard, UK

11:30 #445 Improved renal function and fewer rejection episodes using SDZ RAD in life-supporting hDAF pig to primate renal xenotransplantation.

DJ Ostlie, E Cozzi, CM Vial, FNK Bhatti, G Pino-Chavez, S Thiru, B Soin, DJG White and PJ Friend, Cambridge and Papworth Everard, UK

11:40 #446 Characterization of induced IgG and IgM xenoantibody responses to pig endothelium in humans.

M Kearns-Jonker, J Swensson, W Chu, V Starnes and DV Cramer, Los Angeles, CA

11:50 #447 No evidence of infection with porcine endogenous retrovirus in long term surviving cynomolgus recipients of porcine kidneys. International Young Investigator Award

H Arends, U Martin, M Loss, G Steinhoff and M Winkler, Hannover, Germany

12:00 #448 Inhibition of xenoreactive natural killer cells by a human non-classical HLA class I (HLA-E) expression.

H Sasaki, XC Xu, T Howard and T Mohanakumar, St. Louis, MO

12:10 #449 IFN-y may play a ‘protective’ role in a rat-to-mouse heart transplant model.

H Wang, ME DeVries, B Garcia, D Kelvin and R Zhong, London, ON, Canada

Back to Top

Return to the Agenda